Insider · CIK 0001898490

Farnum Rhonda

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001898490

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	SVP, COMM & MEDICAL AFFAIRS	DDisposition to Issuer	−89.1K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	SVP, COMM & MEDICAL AFFAIRS	DDisposition to Issuer	−150K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	SVP, COMM & MEDICAL AFFAIRS	DDisposition to Issuer	−124K sh	—	—	89,062
2026-09-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−3,329 sh	$17.03	−$56.7K	223,461
2026-09-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−6,657 sh	$17.03	−$113K	213,476
2026-09-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−3,328 sh	$17.03	−$56.7K	220,133
2026-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−5,667 sh	$16.95	−$96.1K	226,790
2026-06-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−6,657 sh	$16.39	−$109K	232,457
2026-06-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−3,328 sh	$16.38	−$54.5K	239,114
2026-06-15	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−3,329 sh	$16.39	−$54.6K	242,442
2026-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−5,678 sh	$16.55	−$94K	245,771
2026-04-01	TBPHTheravance Biopharma, Inc.A Award	SVP, COMM & MEDICAL AFFAIRS	AAward	+18.8K sh	—	—	251,449
2026-03-16	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−7,766 sh	$13.92	−$108K	232,699
2026-03-16	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−7,767 sh	$13.92	−$108K	255,999
2026-03-16	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−15.5K sh	$14.00	−$217K	240,465
2026-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−13.9K sh	$19.66	−$274K	263,766
2025-12-03	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−15.5K sh	$18.75	−$291K	277,695
2025-12-03	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−7,767 sh	$18.75	−$146K	300,995
2025-12-03	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−7,766 sh	$18.75	−$146K	293,229
2025-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,060 sh	$17.90	−$162K	308,762
2025-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,096 sh	$13.39	−$122K	317,822
2025-07-14	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−682 sh	$11.39	−$7,769.821	336,236
2025-07-14	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−5,318 sh	$11.39	−$60.5K	330,918
2025-07-14	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$11.39	−$45.6K	326,918
2025-06-02	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−24K sh	$11.00	−$264K	336,918
2025-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,120 sh	$9.45	−$86.2K	360,918
2025-04-21	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$9.00	−$36K	370,038
2025-02-28	TBPHTheravance Biopharma, Inc.A Award	SVP, COMM & MEDICAL AFFAIRS	AAward	+75K sh	—	—	374,038
2025-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−15.8K sh	$9.66	−$153K	299,038
2025-02-10	TBPHTheravance Biopharma, Inc.A Award	SVP, COMM & MEDICAL AFFAIRS	AAward	+5,283 sh	—	—	314,848
2025-01-21	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$9.00	−$36K	309,565
2024-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,178 sh	$9.97	−$91.5K	313,565
2024-11-11	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$9.00	−$36K	322,743
2024-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,222 sh	$8.22	−$75.8K	326,743
2024-07-10	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$9.00	−$36K	335,965
2024-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−9,268 sh	$9.10	−$84.3K	339,965
2024-04-02	TBPHTheravance Biopharma, Inc.A Award	SVP, COMM & MEDICAL AFFAIRS	AAward	+37.5K sh	—	—	349,233
2024-02-22	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−1,254 sh	$8.71	−$10.9K	311,733
2024-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−18.2K sh	$8.92	−$163K	312,987
2023-11-21	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−1,378 sh	$10.29	−$14.2K	331,206
2023-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−7,982 sh	$10.37	−$82.8K	332,584
2023-08-22	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−1,807 sh	$9.47	−$17.1K	340,566
2023-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−10.5K sh	$9.70	−$101K	342,373
2023-06-08	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−1,790 sh	$11.13	−$19.9K	352,833
2023-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−5,567 sh	$11.21	−$62.4K	354,623
2023-03-09	TBPHTheravance Biopharma, Inc.S Sale	SVP, COMM & MEDICAL AFFAIRS	SSale	−4,000 sh	$10.20	−$40.8K	360,190
2023-03-01	TBPHTheravance Biopharma, Inc.A Award	SVP, COMM & MEDICAL AFFAIRS	AAward	+75K sh	—	—	364,190
2023-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−7,119 sh	$10.44	−$74.3K	289,190
2022-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−23.3K sh	$10.85	−$252K	296,309
2022-08-19	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, COMM & MEDICAL AFFAIRS	FTax Payment	−10.4K sh	$9.34	−$97.3K	319,577

Recent filings

Accepted (ET)
Sep 244
Farnum Rhonda0001898490-26-000017
SEC(opens sec.gov)
Sep 174
Farnum Rhonda0001898490-26-000014
SEC(opens sec.gov)
Aug 244
Farnum Rhonda0001898490-26-000012
SEC(opens sec.gov)
Jun 174
Farnum Rhonda0001898490-26-000010
SEC(opens sec.gov)
May 224
Farnum Rhonda0001898490-26-000008
SEC(opens sec.gov)
Apr 34
Farnum Rhonda0001898490-26-000006
SEC(opens sec.gov)
Mar 184
Farnum Rhonda0001898490-26-000004
SEC(opens sec.gov)
Feb 244
Farnum Rhonda0001898490-26-000002
SEC(opens sec.gov)
Dec 54
Farnum Rhonda0001898490-25-000008
SEC(opens sec.gov)
Nov 244
Farnum Rhonda0001898490-25-000006
SEC(opens sec.gov)

Companies

Theravance Biopharma, Inc.SVP, COMM & MEDICAL AFFAIRSTBPH

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080